EL News Alert Estee Lauder Companies (EL) 82.49 02/14/2015 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Estee Lauder Companies (EL) 82.49 $EL

China Cosmetics Market Worth RMB245.3 Billion by 2017 Says a New Research Report at ChinaMarketResearchReports.com
PRWeb - Fri Feb 13, 6:30PM CST
China's cosmetics market has been booming in recent years and already has become the world's second largest cosmetics consumer market, second only to America, with annual volume of retail sales approximating RMB200 billion. In 2014, influenced by such factors as the economic slowdown, China's cosmetics market registered the lowest growth rate (12.3%) since 2005; the total volume of retail sales of enterprises (each with annual revenue of above RMB20 million) dropped to RMB172.47 billion.
PG: 85.90 (-0.13), EL: 82.49 (+1.58)

After Yesterday's Rally of 1.95% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Feb 13, 3:53PM CST
Estee Lauder (NYSE:EL) traded in a range yesterday that spanned from a low of $80.98 to a high of $82.73. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $81.27 on volume of 3.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EL: 82.49 (+1.58)

Estee Lauder Rises 1.95% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Feb 13, 3:53PM CST
Estee Lauder (NYSE:EL) traded in a range yesterday that spanned from a low of $80.98 to a high of $82.73. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $81.27 on volume of 3.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EL: 82.49 (+1.58)

Investors picking their spots in luxury amid F/X reset
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 11:03AM CST

REV: 33.05 (+0.13), AVP: 9.08 (+0.39), COH: 39.85 (+0.64), TUMI: 22.48 (+0.52), KORS: 73.27 (+1.72), EL: 82.49 (+1.58)

3 Headwinds for Consumer Staples Stocks - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 12:00AM CST
3 Headwinds for Consumer Staples Stocks - Industry Outlook
DPS: 76.95 (-1.35), KO: 41.99 (-0.18), MDLZ: 36.78 (-0.20), GMCR: 118.53 (+0.56), KMB: 111.00 (+0.82), NUS: 56.92 (-1.30), TAP: 72.82 (-0.96), UL: 43.03 (-0.17), EL: 82.49 (+1.58), CCE: 43.69 (-0.66), DEO: 113.89 (-1.40), K: 63.20 (-0.10), PEP: 99.13 (-1.14)

Stock Market News for February 30, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 9:10AM CST
Benchmarks ended in the red on Friday after fresh concerns about Greece’s debt negotiations offset encouraging job report
HRS: 77.73 (+0.42), EXC: 33.51 (-0.93), PFE: 34.64 (-0.23), ORLY: 205.55 (-1.02), DIS: 104.17 (+0.59), DTE: 81.56 (-2.43), HSP: 87.35 (unch), ETR: 79.12 (-1.53), XLS: 24.15 (+0.04), LNKD: 269.00 (+1.83), EXPE: 89.49 (-0.08), GM: 37.62 (-0.40), EL: 82.49 (+1.58), TWTR: 48.50 (+0.55), AEE: 41.54 (-1.12)

Estee Lauder (EL) Stock Gets Price Target Increase at BMO Capital Today
at The Street - Mon Feb 09, 8:42AM CST
Analysts at BMO Capital raised their price target on Estee Lauder (EL) stock.
EL: 82.49 (+1.58)

Own The Portfolio Of The One Percent
Matthew Waterman - at Seeking Alpha - Mon Feb 09, 6:56AM CST

KMI: 41.97 (+0.21), BUD: 121.72 (-0.80), WMT: 85.81 (-0.08), H: 59.51 (-0.14), SHLD: 35.70 (+2.32), NFLX: 466.10 (+9.37), JNJ: 99.62 (+1.18), RCL: 75.56 (-1.19), CPB: 46.88 (-0.84), DD: 76.18 (-0.11), BEN: 53.91 (+0.23), EL: 82.49 (+1.58), BK: 39.20 (-0.21), BF.B: 90.72 (-0.28), EPD: 34.44 (+0.19)

Estee Lauder (EL) Surges: Stock Adds 8.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:04AM CST
The Estee Lauder Companies Inc. (EL) was a big mover last session, as the company saw its shares rise over 8% on the day.
HELE: 77.94 (-0.34), EL: 82.49 (+1.58)

The Estee Lauder Companies' diluted EPS up by 3% in Q2 fiscal 2015
M2 - Fri Feb 06, 6:40AM CST
The Estee Lauder Companies Inc (NYSE:EL) on Thursday reported net earnings attributable to the company of USD435.7m, or USD1.13 per diluted share, for the second quarter of fiscal 2015, ended 31 December 2014.
EL: 82.49 (+1.58)

The Estee Lauder Companies declares USD0.24 per share quarterly dividend
M2 - Fri Feb 06, 6:19AM CST
The Estee Lauder Companies Inc (NYSE:EL), a manufacturer and marketer of quality skin care, makeup, fragrance and hair care products, announced on Thursday that it will pay a quarterly dividend of USD0.24 per share on its Class A and Class B common stock.
EL: 82.49 (+1.58)

Estee Lauder (EL) Beats on Q2 Earnings and Revenues (Revised) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 5:50AM CST
Estee Lauder (EL) Beats on Q2 Earnings and Revenues (Revised)
EL: 82.49 (+1.58)

Estee Lauder
at Investor's Business Daily - Thu Feb 05, 5:34PM CST
Estee Lauder (EL) EPS and sales beat Q2 views. Shares rose 8.1% to a new high of 78.40. Coty (COTY) stock rose 12.2%, also hitting a new high of 21.24 after the cosmetics and fragrance maker topped targets.
COTY: 22.03 (unch), EL: 82.49 (+1.58)

Estee Lauder Rises 8.06% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Feb 05, 3:54PM CST
Estee Lauder (NYSE:EL) traded in a range yesterday that spanned from a low of $74.59 to a high of $78.69. Yesterday, the shares gained 8.1%, which took the trading range above the 3-day high of $73.39 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EL: 82.49 (+1.58)

After Yesterday's Rally of 8.06% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Feb 05, 3:53PM CST
Estee Lauder (NYSE:EL) traded in a range yesterday that spanned from a low of $74.59 to a high of $78.69. Yesterday, the shares gained 8.1%, which took the trading range above the 3-day high of $73.39 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EL: 82.49 (+1.58)

Stocks Rally on Oil Rebound as Dow Turns Positive for 2015
at The Street - Thu Feb 05, 3:19PM CST
Wall Street's focus was on oil Thursday as a rebound in crude prices sparked a rally among equities.
RDS.A: 66.32 (+0.97), GMCR: 118.53 (+0.56), FOXA: 34.72 (+0.31), COP: 69.88 (+1.84), BP: 41.93 (+0.59), EL: 82.49 (+1.58), CVX: 112.78 (+1.92), XLE: 82.04 (+1.70)

Estee Lauder, Coty Hit New Highs On Strong Earnings
at Investor's Business Daily - Thu Feb 05, 1:26PM CST
Shares of cosmetics makers Estee Lauder (EL) and Coty (COTY) sprang to all-time highs Thursday after reporting better-than-expected second-quarter earnings. Estee Lauder's earnings per share rose 3.7% from a year earlier to $1.13, beating analyst...
COTY: 22.03 (unch), EL: 82.49 (+1.58)

Lauder (Estee) Cos (EL) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Thu Feb 05, 12:33PM CST
The following Lauder (Estee) Cos (EL) conference call took place on February 5, 2015, 09:30 AM ET. This is a transcript of that earnings call:
EL: 82.49 (+1.58)

Estee Lauder Beats Q2 Estimates, Lowers 2015 Earnings View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 12:32PM CST
Estee Lauder Companies Inc. (EL) posted solid second-quarter fiscal 2015 results, wherein both earnings and revenues exceeded the Zacks Consensus Estimate. However, the company lowered its earnings view for fiscal 2015.
TLYS: 13.08 (-0.19), HELE: 77.94 (-0.34), SSI: 21.99 (+1.14), EL: 82.49 (+1.58)

Will Foreign Currency Woes Hit Estee Lauder (EL) Earnings? (revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 12:29PM CST
Last quarter, it posted a 60.0% positive earnings surprise. Let’s see how things are shaping up for this announcement.
BEBE: 3.90 (+0.01), DPS: 76.95 (-1.35), RAI: 71.86 (-1.23), EL: 82.49 (+1.58)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 16

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading
Vayo Debuts as Booking Holdings Eyes $100M Investment

Updated Category News Views 3

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Franco-Nevada's Q3 Results Loom: Investors Ready

Updated Category News Views 29

Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 6

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 9

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
Maven Pet's AI Paw-tnership: Changing Pet Care Landscape

Updated Category News Views 19

AI in the World of Doggie Docs In today's tech-driven world, pet owners are turning to artificial intelligence like never before. Forget flipping through outdated dog-care books—nearly half of us are drilling ChatGPT for health tips on our four-legged pals. Yes, it seems we’re asking an AI about Rover's health more than some other major life decisions. But let's face...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 17

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
Omega Point's MCP Secures Anthropic Verification

Updated Category News Views 6

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Continue Reading
Montesodi 2023: A Fresh Chapter in Chianti Excellence

Updated Category News Views 37

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Continue Reading

Top 5 Most Recently Viewed Articles

Victoria Tyler Debuts Lumin & Vale Advisory Service

Updated Category News Views 4

Navigating Life's Crossroads with Victoria Tyler Every once in a while, some folks step up and say, "Hold up, let's rethink how we do things." Victoria Tyler's Lumin & Vale Advisory is doing just that, debuting on July 7, 2026. This isn't your typical coaching gig. Tyler's fresh take hinges on the fascinating dance between choice and circumstance, a mix that defines our...

Continue Reading
VEON Partners with Airspan to Strengthen Ukraine's Network Capabilities

Updated Category News Views 151

VEON and Airspan Forge a New Partnership for Network Resilience In a significant move aimed at enhancing communication infrastructure, VEON Ltd. (NASDAQ: VEON), a leading global digital operator, has entered into a Memorandum of Understanding (MoU) with Airspan Networks Holdings LLC, a prominent U.S.-based provider of Open RAN solutions. This partnership is set to explore...

Continue Reading
Jacobio Pharma Unveils Promising Glecirasib Data in Research

Updated Category News Views 440

Jacobio Pharma Highlights Glecirasib's Clinical Breakthrough Jacobio Pharma, a leading clinical-stage oncology company, has made significant strides with its innovative KRAS G12C inhibitor, glecirasib. The company has announced that the results of its registrational clinical trial have been published in the esteemed journal Nature Medicine. This publication marks a...

Continue Reading
Transforming Homes: Smart Automation Market Set to Surge

Updated Category News Views 185

Market Overview of Smart Home Automation The global smart home automation market is set to experience considerable growth, with projections estimating a rise from USD 74.28 billion in 2023 to an impressive USD 268.97 billion by 2032. This growth indicates a remarkable compound annual growth rate (CAGR) of 15.4% during this forecast period, pointing to a surge in consumer...

Continue Reading
RUA Gold Inc.: Strategies for Gold Market Success Unveiled

Updated Category News Views 207

RUA Gold Inc.: Market Positioning in a Thriving Gold Landscape RUA Gold Inc. is strategically advancing in a favorable gold market, captivating analysts and investors alike. As gold prices remain robust, with expectations pointing towards significant growth, RUA Gold Inc. stands out for its proactive approach and valuable asset portfolio. Current Market Dynamics Favoring...

Continue Reading